[
    [
        {
            "time": "",
            "original_text": "【健帆生物 | 年报预告点评】业绩超预期，预计肾科维持高增长，肝科持续回暖【安信医药马帅团队】",
            "features": {
                "keywords": [
                    "健帆生物",
                    "年报预告",
                    "业绩超预期",
                    "肾科高增长",
                    "肝科回暖"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【健帆生物 | 年报预告点评】业绩超预期，预计肾科维持高增长，肝科持续回暖【安信医药马帅团队】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "600亿市值健帆生物股价连震荡2日 毛利率追贵州茅台",
            "features": {
                "keywords": [
                    "健帆生物",
                    "600亿市值",
                    "股价震荡",
                    "毛利率",
                    "贵州茅台"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "财务指标"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "600亿市值健帆生物股价连震荡2日 毛利率追贵州茅台",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "600亿医疗股暴跌，是谎言还是恶意中伤",
            "features": {
                "keywords": [
                    "600亿医疗股",
                    "暴跌",
                    "谎言",
                    "恶意中伤"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗行业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "600亿医疗股暴跌，是谎言还是恶意中伤",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【健帆生物 | 年报预告继续强推】业绩超预期，预计肾科维持高增长，肝科持续回暖【安信医药马帅团队】",
            "features": {
                "keywords": [
                    "健帆生物",
                    "年报预告",
                    "业绩超预期",
                    "肾科高增长",
                    "肝科回暖"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【健帆生物 | 年报预告继续强推】业绩超预期，预计肾科维持高增长，肝科持续回暖【安信医药马帅团队】",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]